Genetic Aberrations of the K-ras Proto-oncogene in Bladder Cancer in Kashmiri Population

被引:0
|
作者
Nanda, Mahoor S. [1 ,2 ]
Sameer, A. Syed [2 ]
Syeed, Nidda [2 ]
Shah, Zaffar A. [2 ]
Murtaza, Imtiyaz [1 ]
Siddiqi, Mushtaq A. [2 ]
Ali, Arif [1 ]
机构
[1] Jamia Millia Islamia, Dept Biosci, New Delhi 110011, India
[2] Sherikashmir Inst Med Sci, Dept Immunol & Mol Med, Srinagar, Kashmir, India
关键词
proto-oncogene protein; urinary bladder neoplasm; ras genes; genetics; HA-RAS; URINE SEDIMENTS; CELL-CARCINOMA; ONCOGENIC RAS; MUTATIONS; PROGRESSION; METASTASIS; SEQUENCES; CODON-12; TUMORS;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To assess the frequency of specific point mutations in the K-ras gene in a group of Kashmiri patients with bladder cancer. Materials and Methods: We analyzed the incidence of K-ras exon 1 gene mutations in tumors and surgical margins in 60 patients with transitional cell carcinoma of varied clinical stages and histological grades using the polymerase chain reaction-single strand conformation polymorphism and DNA sequencing. Results: A significant correlation was found between the K-ras, the lymph node status, and tumor recurrence (P < 0.05). Also, smokers and patients with higher tumor grade showed a significantly higher relative risk of developing K-ras mutations than the normal ones. Conclusion: K-ras exon 1 gene mutations were found with low frequency in the bladder cancer tumors from Kashmir valley, which suggests that K-ras gene might be involved in a sub-set of bladder tumors, but it needs further investigation on a larger cohort sample to authenticate the current findings.
引用
收藏
页码:168 / 173
页数:6
相关论文
共 50 条
  • [41] The Akt proto-oncogene links Ras to Pak and cell survival signals
    Tang, Y
    Zhou, HL
    Chen, A
    Pittman, RN
    Field, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (13) : 9106 - 9109
  • [42] DETECTION OF POINT MUTATIONS IN K-RAS ONCOGENE IN LUNG-CANCER
    HACKMAN, P
    HUSGAFVELPURSIAINEN, K
    ANTTILA, S
    RIDANPAA, M
    KARJALAINEN, A
    HEIKKILA, L
    VAINIO, H
    MUTATION RESEARCH, 1991, 252 (02): : 203 - 203
  • [43] K-RAS ONCOGENE CODON 12 POINT MUTATIONS IN TESTICULAR CANCER
    RIDANPAA, M
    LOTHE, RA
    ONFELT, A
    FOSSA, S
    BORRESEN, AL
    HUSGAFVELPURSIAINEN, K
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1993, 101 : 185 - 187
  • [44] Establishment of a new invasive urinary bladder cancer model using human c-Ha-ras proto-oncogene transgenic rats
    Wei, Min
    Yamano, Shotaro
    Ishii, Naomi
    Kakehashi, Anna
    Obo, Yumi
    Wanibuchi, Hideki
    CANCER RESEARCH, 2010, 70
  • [45] Proto-oncogene products as target antigens for cancer vaccines
    Halpern, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 11 (04) : 863 - 868
  • [46] Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors
    Vageli, D
    Kiaris, H
    Delakas, D
    Anezinis, P
    Cranidis, A
    Spandidos, DA
    CANCER LETTERS, 1996, 107 (02) : 241 - 247
  • [47] PROTO-ONCOGENE ACTIVATION IN LUNG-CANCER - REPLY
    RODENHUIS, S
    BOS, JL
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (15): : 992 - 992
  • [48] Genetic alterations of the RET proto-oncogene in familial and sporadic pheochromocytomas
    Rodien, P
    Jeunemaitre, X
    Dumont, C
    Beldjord, C
    Plouin, PF
    HORMONE RESEARCH, 1997, 47 (4-6) : 263 - 268
  • [49] Expression of the ETS-1 proto-oncogene in human bladder cancer: Correlation with tumor invasion
    Choi, HY
    Kim, ET
    Ahn, KS
    Bae, EK
    JOURNAL OF UROLOGY, 2003, 169 (04): : 192 - 192
  • [50] Genetic variation in the proto-oncogene SKI and risk for orofacial clefting
    Lu, W
    Volcik, K
    Zhu, HP
    Wen, S
    Shaw, GM
    Lammer, EJ
    Finnell, RH
    MOLECULAR GENETICS AND METABOLISM, 2005, 86 (03) : 412 - 416